Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis

Intrathecal synthesis of central nervous system (CNS)-reactive autoantibodies is observed across patients with autoimmune encephalitis (AE), who show multiple residual neurobehavioral deficits and relapses despite immunotherapies. We leveraged two common forms of AE, mediated by leucine-rich glioma inactivated-1 (LGI1) and contactin-associated protein-like 2 (CASPR2) antibodies, as human models to comprehensively reconstruct and profile cerebrospinal fluid (CSF) B cell receptor (BCR) characteristics. We hypothesized that the resultant observations would both inform the observed therapeutic gap and determine the contribution of intrathecal maturation to pathogenic B cell lineages. From the CSF of three patients, 381 cognate-paired IgG BCRs were isolated by cell sorting and scRNA-seq, and 166 expressed as monoclonal antibodies (mAbs). Sixty-two percent of mAbs from singleton BCRs reacted with either LGI1 or CASPR2 and, strikingly, this rose to 100% of cells in clonal groups with ≥4 members. These autoantigen-reactivities were more concentrated within antibody-secreting cells (ASCs) versus B cells (P < 0.0001), and both these cell types were more differentiated than LGI1- and CASPR2-unreactive counterparts. Despite greater differentiation, autoantigen-reactive cells had acquired few mutations intrathecally and showed minimal variation in autoantigen affinities within clonal expansions. Also, limited CSF T cell receptor clonality was observed. In contrast, a comparison of germline-encoded BCRs versus the founder intrathecal clone revealed marked gains in both affinity and mutational distances (P = 0.004 and P < 0.0001, respectively). Taken together, in patients with LGI1 and CASPR2 antibody encephalitis, our results identify CSF as a compartment with a remarkably high frequency of clonally expanded autoantigen-reactive ASCs whose BCR maturity appears dominantly acquired outside the CNS.

Errataetall:

CommentIn: Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2401337121. - PMID 38354256

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:121

Enthalten in:

Proceedings of the National Academy of Sciences of the United States of America - 121(2024), 7 vom: 13. Feb., Seite e2311049121

Sprache:

Englisch

Beteiligte Personen:

Theorell, Jakob [VerfasserIn]
Harrison, Ruby [VerfasserIn]
Williams, Robyn [VerfasserIn]
Raybould, Matthew I J [VerfasserIn]
Zhao, Meng [VerfasserIn]
Fox, Hannah [VerfasserIn]
Fower, Andrew [VerfasserIn]
Miller, Georgina [VerfasserIn]
Wu, Zoe [VerfasserIn]
Browne, Eleanor [VerfasserIn]
Mgbachi, Victor [VerfasserIn]
Sun, Bo [VerfasserIn]
Mopuri, Rohini [VerfasserIn]
Li, Ying [VerfasserIn]
Waters, Patrick [VerfasserIn]
Deane, Charlotte M [VerfasserIn]
Handel, Adam [VerfasserIn]
Makuch, Mateusz [VerfasserIn]
Irani, Sarosh R [VerfasserIn]

Links:

Volltext

Themen:

Autoantibodies
Autoantibody
Autoantigen
Autoantigens
Cerebrospinal fluid
Encephalitis
GMW67QNF9C
Intracellular Signaling Peptides and Proteins
Journal Article
LGI1 protein, human
Leucine
Plasmablast

Anmerkungen:

Date Completed 08.02.2024

Date Revised 13.03.2024

published: Print-Electronic

CommentIn: Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2401337121. - PMID 38354256

Citation Status MEDLINE

doi:

10.1073/pnas.2311049121

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368093913